Showing 16,981 - 17,000 results of 18,626 for search '"Therapy"', query time: 0.12s Refine Results
  1. 16981

    Lobectomy in Patients with Cystic Fibrosis by Shahid I Sheikh, Karen McCoy, Nancy A Ryan-Wenger, Alpa Patel, Stephen Kirkby

    Published 2014-01-01
    “…BACKGROUND: Some patients with cystic fibrosis (CF) develop severe but localized lung disease or recurrent hemoptysis/pneumothorax refractory to conventional medical therapies.…”
    Get full text
    Article
  2. 16982

    Current advances in multimodal imaging in geographic atrophy secondary to age-related macular degeneration: A review by Amy C. Cohn, Robyn H. Guymer

    Published 2024-12-01
    “…These advancements have allowed novel imaging biomarkers to be used as end points in large interventional studies exploring new therapies for GA treatment. Due to differences in drug approval timing, ophthalmologists in some jurisdictions are already treating patients with complement inhibiting intravitreal therapies and using MMI to guide management. …”
    Get full text
    Article
  3. 16983
  4. 16984

    Automated quantification of axonal and myelin changes in contusion, dislocation, and distraction spinal cord injuries: Insights into targeted remyelination and axonal regeneration by Xuan Li, Yuan He, Fangyao Chen, Xin Tong, Yunlong Fan, Yuzhe Langzhou, Jie Liu, Kinon Chen

    Published 2025-02-01
    “…These results indicate that remyelination therapies may be most effective for distraction injuries, where preserved axons make remyelination crucial, while axonal regeneration therapies are likely better suited for dislocation injuries with extensive axonal loss. …”
    Get full text
    Article
  5. 16985

    Enhanced Antitumor Immune Response in 2′-5′ Oligoadenylate Synthetase-Like 1- (OASL1-) Deficient Mice upon Cisplatin Chemotherapy and Radiotherapy by Chan Kyu Sim, Jung Hoon Lee, In-Jeoung Baek, Sang-Wook Lee, Myeong Sup Lee

    Published 2019-01-01
    “…Collectively, these results show that targeting OASL1 together with conventional cancer therapies could be an effective strategy to enhance treatment efficacy.…”
    Get full text
    Article
  6. 16986

    Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection by Matteo Megna, Cataldo Patruno, Maria Rita Bongiorno, Alessio Gambardella, Claudio Guarneri, Caterina Foti, Serena Lembo, Francesco Loconsole, Gabriella Fabbrocini

    Published 2022-07-01
    “…Background Some biologics for psoriasis, especially anti-tumor necrosis factor (TNF)-α therapies, may re-activate latent tuberculosis (TBC) infection with consequent morbidity and mortality. …”
    Get full text
    Article
  7. 16987

    Le Domaine des Co-infections et des Maladies Concomitantes du Réseau Canadien pour les Essais VIH des IRSC : Lignes Directrices Canadiennes pour la Prise en Charge et le Traitement... by Mark Hull, Pierre Giguère, Marina Klein, Stephen Shafran, Alice Tseng, Pierre Côté, Marc Poliquin, Curtis Cooper

    Published 2014-01-01
    “…La prise en charge du VIH et du VHC est plus complexe en raison de l’évolution accélérée de la maladie hépatique, du choix et des critères d’initiation de la thérapie antirétrovirale et du traitement anti-VHC, de la prise en charge de la santé mentale et des toxicomanies, des obstacles socioéconomiques et des interactions entre les nouvelles thérapies antivirales à action directe du VHC et les antirétroviraux…”
    Get full text
    Article
  8. 16988

    Peripheral Nerve Regeneration Using Different Germ Layer-Derived Adult Stem Cells in the Past Decade by Yu Li, Yuzuru Kamei, Miki Kambe, Katsumi Ebisawa, Mayumi Oishi, Keisuke Takanari

    Published 2021-01-01
    “…We concluded that adult stem cell-based therapies promote the regeneration of PNI in various ways.…”
    Get full text
    Article
  9. 16989

    Receptor Tyrosine Kinases and Inhibitors in Lung Cancer by Evan Pisick, Simha Jagadeesh, Ravi Salgia

    Published 2004-01-01
    “…The receptor tyrosine kinases (RTKs) located at the cellular membrane are becoming of great interest as sites for targeted therapies for lung cancers. This review will discuss the RTKs that are involved in lung cancers and the newer therapies that are being tested. …”
    Get full text
    Article
  10. 16990

    Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success by Lanfranco Pellesi, Lars Edvinsson

    Published 2025-01-01
    “…This approach aims to establish proof of concept for substance P’s role in migraine, laying the groundwork for investigations with animal and cell-based models and advancing the development of innovative treatments for patients refractory to current therapies.…”
    Get full text
    Article
  11. 16991

    Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable by Wu Helena T., Hsu Vanessa, Win Shwe, Xing Yan

    Published 2025-01-01
    “…Despite their success, these therapies are associated with immune-related adverse events including rare but severe immunotherapy-related cardiotoxicities. …”
    Get full text
    Article
  12. 16992

    Psoriatic arthritis: An up to date overview by Simon Hackett, Laura Coates

    Published 2020-01-01
    “…Therapies have shown that robust treatment in patients, achieving tight disease control, improves outcomes and overall quality of life. …”
    Get full text
    Article
  13. 16993

    Nicotine Replacement Combined with a Novel Compound (ProBAN) for Smoking Cessation: A Pilot Study by Richard Leigh, Norman M Viner, Gerard Cox, Jeffrey W Balon, Douglas MC Wilson, Denise O’Shaughnessy, Corinne Walker, Gerry Brosky, Malcolm R Sears

    Published 2001-01-01
    “…BACKGROUND: Smoking cessation rates with available pharmacological therapies remain suboptimal. Anecdotal observations with a combination of sublingual pralidoxime and ipratropium (ProBAN) suggested that these agents in combination with nicotine gum improved quit rates.…”
    Get full text
    Article
  14. 16994

    Adrenaline Injection Plus Argon Plasma Coagulation versus Adrenaline Injection Plus Hemoclips for Treating High-Risk Bleeding Peptic Ulcers: A Prospective, Randomized Trial by Seyed Alireza Taghavi, Seyed Mohammad Soleimani, Seyed Mohammad Kazem Hosseini-Asl, Ahad Eshraghian, Hajar Eghbali, Seyed Mohsen Dehghani, Bita Ahmadpour, Mehdi Saberifiroozi

    Published 2009-01-01
    “…BACKGROUND/OBJECTIVE: Several combination endoscopic therapies are currently in use. The present study aimed to compare argon plasma coagulation (APC) + adrenaline injection (AI) with hemoclips + AI for the treatment of high-risk bleeding peptic ulcers.…”
    Get full text
    Article
  15. 16995

    Morphology of Helicobacter pylori as a result of peptidoglycan and cytoskeleton rearrangements by Paweł Krzyżek, Grażyna Gościniak

    Published 2018-09-01
    “…In addition, the existence of proteins associated with modifications of H. pylori morphology as potential targets in therapies reducing the virulence of this bacterium has been suggested.…”
    Get full text
    Article
  16. 16996

    Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins by Alison Smith, Hugh Manoli, Stacey Jaw, Kimberley Frutoz, Alan L. Epstein, Leslie A. Khawli, Frank-Peter Theil

    Published 2016-01-01
    “…Biologics have emerged as a powerful and diverse class of molecular and cell-based therapies that are capable of replacing enzymes, editing genomes, targeting tumors, and more. …”
    Get full text
    Article
  17. 16997

    Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation by Yur-Ren Kuo, Chien-Chang Chen, Shigeru Goto, Pao-Yuan Lin, Fu-Chan Wei, Chao-Long Chen

    Published 2012-01-01
    “…In this paper, we summarize the current understanding of immunomodulation achieved by MSC therapies and introduce a possible outline for future clinical applications in VCA.…”
    Get full text
    Article
  18. 16998

    Bone Marrow Stem Cell as a Potential Treatment for Diabetes by Ming Li, Susumu Ikehara

    Published 2013-01-01
    “…However, these therapies fail to maintain blood glucose levels in the normal range all the time. …”
    Get full text
    Article
  19. 16999

    Neuroplasticity in Alzheimer's disease: a therapeutic alternative at the molecular level by Noel Jesús Niebla Gómez, Rodolfo Javier Rivero Morey, Víctor René Navarro Machado, Mariangel González León, Amanda Martínez Pérez

    Published 2020-08-01
    “…The neuroplasticity mechanisms of the organism form the basis of dissimilar therapies that seek to potentiate such effects to achieve relative improvement in a large number of neurodegenerative diseases. …”
    Get full text
    Article
  20. 17000

    Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma by Caroline Y. K. Fong, Emma Burke, David Cunningham, Naureen Starling

    Published 2019-01-01
    “…Research has since focussed on understanding the role and interplay between various components of the desmoplastic stroma and tumour microenvironment, in addition to developing targeted therapies based on molecular features to improve the prognosis associated with this malignancy. …”
    Get full text
    Article